Class information for: |
Basic class information |
Class id | #P | Avg. number of references |
Database coverage of references |
---|---|---|---|
2870 | 2126 | 40.1 | 62% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
21 | 4 | UROLOGY & NEPHROLOGY//UROL//JOURNAL OF UROLOGY | 229838 |
612 | 3 | ANABOLIC STEROIDS//CLENBUTEROL//ANABOLIC ANDROGENIC STEROIDS | 14056 |
2266 | 2 | ANABOLIC ANDROGENIC STEROIDS//KHAT//ANABOLIC STEROIDS | 4657 |
2870 | 1 | ANABOLIC ANDROGENIC STEROIDS//ANABOLIC STEROIDS//NANDROLONE DECANOATE | 2126 |
Terms with highest relevance score |
rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|---|
1 | ANABOLIC ANDROGENIC STEROIDS | authKW | 2389996 | 11% | 71% | 234 |
2 | ANABOLIC STEROIDS | authKW | 1219284 | 11% | 36% | 238 |
3 | NANDROLONE DECANOATE | authKW | 511094 | 3% | 57% | 62 |
4 | ANDROGENIC ANABOLIC STEROIDS | authKW | 309668 | 1% | 74% | 29 |
5 | BODYBUILDERS | authKW | 294091 | 2% | 64% | 32 |
6 | PERFORMANCE ENHANCING DRUGS | authKW | 288678 | 1% | 72% | 28 |
7 | MUSCLE DYSMORPHIA | authKW | 284322 | 2% | 60% | 33 |
8 | BODYBUILDING | authKW | 257383 | 2% | 41% | 44 |
9 | NANDROLONE | authKW | 241060 | 2% | 34% | 49 |
10 | PERFORMANCE ENHANCING SUBSTANCES | authKW | 236184 | 1% | 66% | 25 |
Web of Science journal categories |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | Sport Sciences | 25601 | 26% | 0% | 548 |
2 | Substance Abuse | 8074 | 9% | 0% | 197 |
3 | Hospitality, Leisure, Sport & Tourism | 4197 | 4% | 0% | 87 |
4 | Primary Health Care | 1436 | 3% | 0% | 57 |
5 | Psychiatry | 1059 | 9% | 0% | 192 |
6 | Endocrinology & Metabolism | 787 | 9% | 0% | 182 |
7 | Behavioral Sciences | 633 | 4% | 0% | 92 |
8 | Psychology | 523 | 4% | 0% | 83 |
9 | Orthopedics | 504 | 5% | 0% | 101 |
10 | Medicine, General & Internal | 423 | 8% | 0% | 173 |
Address terms |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | BIOL DRUG DEPENDENCE | 71214 | 1% | 18% | 28 |
2 | ELETROFISIOL CARDIACA ANTONIO PAES DE CARVALH | 43083 | 0% | 100% | 3 |
3 | SOCIAL POLIT SCI SSP | 32311 | 0% | 75% | 3 |
4 | MIGUEL HERNANDEZ | 28722 | 0% | 100% | 2 |
5 | ZAKLAD BADAN ANTYDOPINGOWYCH | 28722 | 0% | 100% | 2 |
6 | EATING WEIGHT DISORDERS PROGRAM | 27020 | 0% | 24% | 8 |
7 | CLUB CARDIOL SPORT | 19147 | 0% | 67% | 2 |
8 | STATE VAUD HEP VD | 19147 | 0% | 67% | 2 |
9 | UMR 6018 PHYSIOL GEN | 19147 | 0% | 67% | 2 |
10 | ADM VIDY | 18461 | 0% | 43% | 3 |
Journals |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | PHYSICIAN AND SPORTSMEDICINE | 17094 | 2% | 3% | 47 |
2 | SUBSTANCE ABUSE TREATMENT PREVENTION AND POLICY | 13023 | 1% | 5% | 19 |
3 | INTERNATIONAL JOURNAL OF SPORTS MEDICINE | 7051 | 2% | 1% | 46 |
4 | BRITISH JOURNAL OF SPORTS MEDICINE | 6085 | 2% | 1% | 39 |
5 | SCIENCE & SPORTS | 5226 | 1% | 2% | 19 |
6 | SPORT MANAGEMENT REVIEW | 4750 | 0% | 4% | 9 |
7 | SPORTS MEDICINE | 4606 | 1% | 1% | 27 |
8 | SCANDINAVIAN JOURNAL OF MEDICINE & SCIENCE IN SPORTS | 4022 | 1% | 1% | 24 |
9 | SUBSTANCE USE & MISUSE | 3874 | 1% | 1% | 27 |
10 | HORMONES AND BEHAVIOR | 3622 | 1% | 1% | 29 |
Author Key Words |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | ANABOLIC ANDROGENIC STEROIDS | 2389996 | 11% | 71% | 234 | Search ANABOLIC+ANDROGENIC+STEROIDS | Search ANABOLIC+ANDROGENIC+STEROIDS |
2 | ANABOLIC STEROIDS | 1219284 | 11% | 36% | 238 | Search ANABOLIC+STEROIDS | Search ANABOLIC+STEROIDS |
3 | NANDROLONE DECANOATE | 511094 | 3% | 57% | 62 | Search NANDROLONE+DECANOATE | Search NANDROLONE+DECANOATE |
4 | ANDROGENIC ANABOLIC STEROIDS | 309668 | 1% | 74% | 29 | Search ANDROGENIC+ANABOLIC+STEROIDS | Search ANDROGENIC+ANABOLIC+STEROIDS |
5 | BODYBUILDERS | 294091 | 2% | 64% | 32 | Search BODYBUILDERS | Search BODYBUILDERS |
6 | PERFORMANCE ENHANCING DRUGS | 288678 | 1% | 72% | 28 | Search PERFORMANCE+ENHANCING+DRUGS | Search PERFORMANCE+ENHANCING+DRUGS |
7 | MUSCLE DYSMORPHIA | 284322 | 2% | 60% | 33 | Search MUSCLE+DYSMORPHIA | Search MUSCLE+DYSMORPHIA |
8 | BODYBUILDING | 257383 | 2% | 41% | 44 | Search BODYBUILDING | Search BODYBUILDING |
9 | NANDROLONE | 241060 | 2% | 34% | 49 | Search NANDROLONE | Search NANDROLONE |
10 | PERFORMANCE ENHANCING SUBSTANCES | 236184 | 1% | 66% | 25 | Search PERFORMANCE+ENHANCING+SUBSTANCES | Search PERFORMANCE+ENHANCING+SUBSTANCES |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
---|---|---|---|---|
1 | POPE, HG , WOOD, RI , ROGOL, A , NYBERG, F , BOWERS, L , BHASIN, S , (2014) ADVERSE HEALTH CONSEQUENCES OF PERFORMANCE-ENHANCING DRUGS: AN ENDOCRINE SOCIETY SCIENTIFIC STATEMENT.ENDOCRINE REVIEWS. VOL. 35. ISSUE 3. P. 341-375 | 193 | 62% | 28 |
2 | HARTGENS, F , KUIPERS, H , (2004) EFFECTS OF ANDROGENIC-ANABOLIC STEROIDS IN ATHLETES.SPORTS MEDICINE. VOL. 34. ISSUE 8. P. 513 -554 | 150 | 79% | 303 |
3 | SAGOE, D , MOLDE, H , ANDREASSEN, CS , TORSHEIM, T , PALLESEN, S , (2014) THE GLOBAL EPIDEMIOLOGY OF ANABOLIC-ANDROGENIC STEROID USE: A META-ANALYSIS AND META-REGRESSION ANALYSIS.ANNALS OF EPIDEMIOLOGY. VOL. 24. ISSUE 5. P. 383-398 | 106 | 85% | 33 |
4 | KANAYAMA, G , HUDSON, JI , POPE, HG , (2008) LONG-TERM PSYCHIATRIC AND MEDICAL CONSEQUENCES OF ANABOLIC-ANDROGENIC STEROID USE: A LOOMING PUBLIC HEALTH CONCERN?.DRUG AND ALCOHOL DEPENDENCE. VOL. 98. ISSUE 1-2. P. 1 -12 | 113 | 88% | 87 |
5 | KANAYAMA, G , HUDSON, JI , POPE, HG , (2010) ILLICIT ANABOLIC-ANDROGENIC STEROID USE.HORMONES AND BEHAVIOR. VOL. 58. ISSUE 1. P. 111 -121 | 125 | 74% | 63 |
6 | MHILLAJ, E , MORGESE, MG , TUCCI, P , BOVE, M , SCHIAVONE, S , TRABACE, L , (2015) EFFECTS OF ANABOLIC-ANDROGENS ON BRAIN REWARD FUNCTION.FRONTIERS IN NEUROSCIENCE. VOL. 9. ISSUE . P. - | 110 | 74% | 2 |
7 | ONAKOMAIYA, MM , HENDERSON, LP , (2016) MAD MEN, WOMEN AND STEROID COCKTAILS: A REVIEW OF THE IMPACT OF SEX AND OTHER FACTORS ON ANABOLIC ANDROGENIC STEROIDS EFFECTS ON AFFECTIVE BEHAVIORS.PSYCHOPHARMACOLOGY. VOL. 233. ISSUE 4. P. 549 -569 | 129 | 49% | 1 |
8 | TURILLAZZI, E , PERILLI, G , DI PAOLO, M , NERI, M , RIEZZO, I , FINESCHI, V , (2011) SIDE EFFECTS OF AAS ABUSE: AN OVERVIEW.MINI-REVIEWS IN MEDICINAL CHEMISTRY. VOL. 11. ISSUE 5. P. 374 -389 | 97 | 72% | 21 |
9 | THIBLIN, I , PETERSSON, A , (2005) PHARMACOEPIDEMIOLOGY OF ANABOLIC ANDROGENIC STEROIDS: A REVIEW.FUNDAMENTAL & CLINICAL PHARMACOLOGY. VOL. 19. ISSUE 1. P. 27-44 | 86 | 91% | 75 |
10 | KANAYAMA, G , BROWER, KJ , WOOD, RI , HUDSON, JI , POPE, HG , (2009) ANABOLIC-ANDROGENIC STEROID DEPENDENCE: AN EMERGING DISORDER.ADDICTION. VOL. 104. ISSUE 12. P. 1966 -1978 | 90 | 75% | 61 |
Classes with closest relation at Level 1 |